| Host: |
Rabbit |
| Applications: |
IF |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-MSMB (21-114) is suitable for use in Immunofluorescence research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
IF 1:50-1:200 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
MSMB |
| Gene ID: |
4477 |
| Uniprot ID: |
MSMB_HUMAN |
| Immunogen Region: |
21-114 |
| Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 21-114 of human MSMB (NP_002434.1). |
| Immunogen Sequence: |
SCYFIPNEGVPGDSTRKCMD LKGNKHPINSEWQTDNCETC TCYETEISCCTLVSTPVGYD KDNCQRIFKKEDCKYIVVEK KDPKKTCSVSEWII |
| Tissue Specificity | Strongly expressed in prostate, liver, kidney, breast and penis. Also expressed in pancreas, esophagus, stomach, deodenum, colon, trachea, lung, salivary glands and fallopian tube. PSP94 is expressed in lung and breast, whereas PSP57 is found in kidney and bladder. |
| Protein Name | Beta-MicroseminoproteinImmunoglobulin-Binding FactorIgbfPn44Prostate Secreted Seminal Plasma ProteinProstate Secretory Protein Of 94 Amino AcidsPsp-94Psp94Seminal Plasma Beta-Inhibin |
| Cellular Localisation | SecretedSperm Surface |
| Alternative Antibody Names | Anti-Beta-Microseminoprotein antibodyAnti-Immunoglobulin-Binding Factor antibodyAnti-Igbf antibodyAnti-Pn44 antibodyAnti-Prostate Secreted Seminal Plasma Protein antibodyAnti-Prostate Secretory Protein Of 94 Amino Acids antibodyAnti-Psp-94 antibodyAnti-Psp94 antibodyAnti-Seminal Plasma Beta-Inhibin antibodyAnti-MSMB antibodyAnti-PRSP antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
